J. Virol., Jun 1996, 3407-3415, Vol 70, No. 6
Copyright © 1996, American Society for Microbiology

Folding, assembly, and intracellular trafficking of the human immunodeficiency virus type 1 envelope glycoprotein analyzed with monoclonal antibodies recognizing maturational intermediates

A Otteken, PL Earl and B Moss
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892-0455, USA.

Monoclonal antibodies (MAbs) that bind linear or conformational epitopes on monomeric or oligomeric human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins were screened for their recognition of maturational intermediates. On the basis of reactivities with gp160 at different times after pulse-labeling, the MAbs were sorted into groups that exhibited binding which was immediate and constant, immediate but transient, delayed, late, or very late. This grouping was consistent with the selectivity of the MAbs for structural features of gp160. Thus, a MAb to the V3 loop reacted with envelope proteins at all times, in accord with the relative conformational independence and accessibility of the epitope. Several MAbs that preferentially react with monomeric gp160 exhibited diminished binding after the pulse. A 10- min tag occurred before gp160 reacted with conformational MAbs that inhibited CD4 binding. The availability of epitopes for other conformational MAbs, including some that react equally with monomeric and oligomeric gp160 and some that react better with oligomeric forms, was half-maximal in 30 min and closely followed the kinetics of gp160 oligomerization. Remarkably, there was a 1- to 2-h delay before gp160 reacted with stringent oligomer-specific MAbs. After 4 h, approximately 20% of the gp160 was recognized by these MAbs. Epitopes recognized by monomerspecific or CD4-blocking MAbs but not by oligomer-dependent MAbs were present on gp160 molecules associated with the molecular chaperone BiP/GRP78. MAbs with a preference for monomers reacted with recombinant or HIV-1 envelope proteins in the endoplasmic reticulum, whereas the oligomer-specific MAbs recognized them in the Golgi complex. Additional information regarding gp160 maturation and intracellular trafficking was obtained by using brefeldin A, dithiothreitol, and a low temperature.

This article has been cited by other articles:

• Shang, L., Yue, L., Hunter, E. (2008). Role of the Membrane-Spanning Domain of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein in Cell-Cell Fusion and Virus Infection. J. Virol. 82: 5417-5428 [Abstract] [Full Text]  
• Yang, X., Kurteva, S., Lee, S., Sodroski, J. (2005). Stoichiometry of Antibody Neutralization of Human Immunodeficiency Virus Type 1. J. Virol. 79: 3500-3508 [Abstract] [Full Text]  
• LAND, A., ZONNEVELD, D., BRAAKMAN, I. (2003). Folding of HIV-1 Envelope glycoprotein involves extensive isomerization of disulfide bonds and conformation-dependent leader peptide cleavage. FASEB J. 17: 1058-1067 [Abstract] [Full Text]  
• Miranda, L. R., Schaefer, B. C., Kupfer, A., Hu, Z., Franzusoff, A. (2002). Cell surface expression of the HIV-1 envelope glycoproteins is directed from intracellular CTLA-4-containing regulated secretory granules. Proc. Natl. Acad. Sci. USA 99: 8031-8036 [Abstract] [Full Text]  
• Bültmann, A., Muranyi, W., Seed, B., Haas, J. (2001). Identification of Two Sequences in the Cytoplasmic Tail of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein That Inhibit Cell Surface Expression. J. Virol. 75: 5263-5276 [Abstract] [Full Text]  
• Binley, J. M., Sanders, R. W., Clas, B., Schuelke, N., Master, A., Guo, Y., Kajumo, F., Anselma, D. J., Maddon, P. J., Olson, W. C., Moore, J. P. (2000). A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure. J. Virol. 74: 627-643 [Abstract] [Full Text]  
• Knarr, G., Modrow, S., Todd, A., Gething, M.-J., Buchner, J. (1999). BiP-binding Sequences in HIV gp160. IMPLICATIONS FOR THE BINDING SPECIFICITY OF BiP. J. Biol. Chem. 274: 29850-29857 [Abstract] [Full Text]  
• Rosenberg, A. R., Delamarre, L., Pique, C., Le Blanc, I., Griffith, G., Dokhelar, M.-C. (1999). Early Assembly Step of a Retroviral Envelope Glycoprotein: Analysis Using a Dominant Negative Assay. J. Cell Biol. 145: 57-68 [Abstract] [Full Text]  
• Sullivan, N., Sun, Y., Binley, J., Lee, J., Barbas, C. F. III, Parren, P. W. H. I., Burton, D. R., Sodroski, J. (1998). Determinants of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Activation by Soluble CD4 and Monoclonal Antibodies. J. Virol. 72: 6332-6338 [Abstract] [Full Text]  
• Zhu, Z.-B., Atkinson, T. P., Volanakis, J. E. (1998). A Novel Type II Complement C2 Deficiency Allele in an African-American Family. J. Immunol. 161: 578-584 [Abstract] [Full Text]  
• McInerney, T. L., El Ahmar, W., Kemp, B. E., Poumbourios, P. (1998). Mutation-Directed Chemical Cross-Linking of Human Immunodeficiency Virus Type 1 gp41 Oligomers. J. Virol. 72: 1523-1533 [Abstract] [Full Text]  
• Ruddon, R. W., Bedows, E. (1997). Assisted Protein Folding. J. Biol. Chem. 272: 3125-3128 [Full Text]